Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
Apply
HC-7366 & Nivolumab
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step